CAS NO.: 148031-34-9
Assay: 98.5% min.
Gradus: Pharmaceutical Grade
Repono: Stricta in conserva, lux repugnans continentia, thesaurizate in armario(2-8° C)
Formulae hypotheticae: C35H49N11O9S2
M. pondus: 831.96
Aspectus: Pulvis albus
Sequentia: Mpr-Harg-Gly-Asp-Trp-Pro-Cys)-NH2
Eptifibatide (Integerlin, Millennium Pharmaceuticals, etiam co-promota a Schering aratro / Essexium), Antiplatelet medicamentum glycoprotein IIb/IIIa inhibitoris class.Eptifibatide est cyclica heptapeptidis ducta ex interdum in venenis pygmiae orientalis rattlesnake. (Sistrurus miliarius barbouri). Ad genus pertinet glycin aspartat-mimaticorum sic dicti arginin et reversibly ligamentum ad platelets. Eptifibatide breve dimidium-vitae habet. Medicamentum est tertium inhibitoris GPIIb/IIIa quae acceptionem latam invenit post specifica anticorpus abciximabum et tirofiban non-peptidum globalis forum ingressus..
1 . Eptifibatide adhibetur ad reducendum periculum eventuum ischemicorum cardiaci acuti (mors et / vel myocardiaca infarctione) aegris cum instabili angina vel non-ST-semen-elatio (e.g., non-Q-unda) myocardiaca infarctione (i.e., elevatio syndromes coronariae acutae segmentum non-ST) tam in aegris, qui non surgery recipiant (optimatium) curationis medicae et interventus coronarii percutaneos sustinentes (PCI).
2 .adultos et filios tractare supra6 annos vetus humanitas vitium virus(HIV)inficit. vitium inveteratum virus(HIV)inficit.
